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is used. One innovation of the paper is that we treat agency and finance effects 




RESEARCH AND DEVELOPMENT, CASH FLOW, AGENCY AND 
GOVERNANCE: UK LARGE COMPANIES 
 
1.INTRODUCTION 
The contribution of R&D to economic growth has become a policy issue in recent 
years especially following the success of high-technology growth in the USA from the 
mid 1990s. Some have argued that this focus is exaggerated and that other 
channels such as the diffusion of general purpose technology are of equal if not 
greater importance (Hughes 2007). Nevertheless, R&D contributes strongly to 
economic growth as attested to by individual studies (Wakelin 2001) and the digest 
of results in Greenhaugh and Rogers (2010). Most of these studies seem to confirm 
a private return over and above the likely cost of capital, though the time pattern 
appears not to be stable (Kafouros 2005; Lang 2009). At industry level, recent UK 
research shows a strong direct effect of R&D on productivity growth for firms carrying 
out the research; spillovers also occur for non-performing R&D players, but with the 
main gains accruing to other R&D active firms, thus amplifying the gains from this 
form of innovation expenditure (O’Mahony and Vecchi 2009).  
 Given the importance of R&D for performance, the policy debate has turned to 
reasons why some firms or regions allocate more resources to it than others 
(Moncada-Paterno-Casada et al 2010). For some, the answer lies in finance 
constraints. R&D is highly uncertain in terms of appropriability, subject to asymmetric 
information, intensive in sunk cost, and with a long pay-off; firms may therefore be 
driven to adopt short-run horizons to reassure arms-length investors, to the detriment 
of long-run R&D projects, which arguably require patient capital, close oversight and 
engaged investors. Others, however, argue that the provision of finance is best 
assured by institutional forms that permit liquidity and ensure exit options for 
investors. The debate is mirrored in the institutional labour market literature where on 
the one hand, tenure and tolerance of failure is said to favour risk-taking by 
employees while on the other the need for creative destruction and rapid reallocation 
in some industries appears to favour top-down control. 
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These issues form a set of debates that go under the rubric of corporate governance. 
Given the international variety in the institutions of governance there has been a 
wide-ranging debate as to whether innovation profiles in different regions such as the 
UK, US, mainland Europe and Japan can be explained in these terms  - the varieties 
of capitalism debate (Hall and Soskice eds 2001; Hancke 2009). There is some 
controversy over whether a mapping exists from distinct institutional forms of 
capitalism to comparative advantage for particular sectors or technologies (Lundval 
2002; Taylor 2004; Tylecote and Ramirez 2006; Crouch and Voelzkow 2009; Casper 
2009). Whatever the outcome of this controversy, there is increasing interest in the 
role of corporate governance in technology choices. The innovation literature is 
accumulating studies in respect of ownership structure (Calderini et al 2003; Munari 
et al 2010); the role of short termism and finance ( Hall 2002, O’Sullivan 2005, 
Demirag and Doi 2007); or of board composition and design (Munari and Sobrero 
2003; Kor 2006). Indeed, Tylecote (2007) claims that corporate governance is now 
central to determining “firms’ efforts in innovation and technological change” 
(p.1476). That is the main idea that we wish to explore further in this paper, where 
our interest is in estimating the direction and significance of any impact.  However, 
our focus will be narrower and more specific than in some previous work. In 
particular, we look at the R&D expenditure by large corporations incorporated and 
listed in the UK.  
2.CORPORATE GOVERNANCE AND FINANCE: EFFECTS ON INNOVATION 
 
At least from the 1970s, corporate governance of shareholder economies has been 
viewed narrowly, as a system of control in which shareholder interests are dominant. 
Earlier there had been a loose consensus that managers should (or did) exercise 
autonomous control of the firm of the firm (managerial capitalism). Shareholder 
orientation of firms gained ground first in the United States where international 
competition caused investors to seek higher returns and more accountability from 
executive management.  The theoretical framework underpinning this approach is 
that of “principal-agent” where the principal normally refers to the owner or investor 
and the agent to the manager or worker who is hired under a fully specified or 




The challenge of principal agent theory is to design a system that aligns the interests 
of owners and managers, since the owner cannot always infer or observe effort 
(Eisenhardt 1989). Corporate governance is an institutional form that addresses this 
problem; the costs incurred in setting up these governance mechanisms form part of 
what are known as agency costs.  These include monitoring arrangements or more 
usually an incentive system to persuade managers to take risk. In recent years, a 
number of corporate governance codes, national and transnational, have been 
agreed that set out principles or rules to safeguard the interests of owners. These 
include transparency and oversight through good design of the board of directors, 
and approaches to incentivising senior management (Higgs 2003, OECD 2004). It is 
now common for companies to be assessed using a corporate governance index 
that records the extent of compliance with such codes (Gompers et al 2003; Higgs 
2003). 
 
The application of a governance code is expected to have virtuous effects that 
operate through two channels. First, it may reduce the cost of funds (cost of capital) 
for long-run and uncertain projects such as capital and innovation investment. 
Second, it may directly affect decision-making in a way that reduces self-serving 
behaviour by managers. In this article, in keeping with much of the literature, we 
refer to these principal-agent mechanisms as “good governance”, but without 
necessarily ascribing to that term any approbation. A third channel of influence from 
governance to R&D contradicts the supposed benefits of close alignment of manager 
and owner interests. In particular, some observers see a danger in “over-monitoring” 
that reduces managerial autonomy (Baysinger 1991, Aghion and Tirole 1997). It is  
argued that innovation may suffer where owners are removed from the sources of 
technical knowledge (Lazonick 2008).  Furthermore, the interests of owners may 
conflict with innovation investments when  owners are disposed to favour liquid 
assets in preference to long-term sunk and uncertain ones. Ultimately it is an 
empirical matter whether governance supports R&D expenditure (through 





The above is necessarily a very compressed view of the mechanisms by which 
governance affects innovation.3 Nevertheless it allows a simple framework that can 
inform the empirical work in this article. We aim to test the principal agent views 
against the alternative idea that many of the mechanisms of “good government” may 
have perverse consequences for innovation.  To that end we first test the proposition 
that governance encourages innovation by improving the terms of finance or the 
barriers to raising finance. Financial investors do not always know or care which 
specific projects within a company that money is being raised for. Their concern is 
whether governance procedures are in place to protect their investments. Thus 
insofar as governance encourages R&D through reducing finance constraints, we 
expect that the governance variable that is relevant is a general, or aggregated,  
index of governance that financial investors tend to monitor. We will construct such 
as index (CG) by reference to the literature in this area. 
 
The second channel of influence from governance to innovation is also set within the 
principal agent framework and concerns the direct effect of more transparency, 
better monitoring or more aligned incentives on the management of innovation. Our 
focus here will be on the elements of governance most likely to address the specific 
need to generate appropriate levels of innovation investment. To this end we 
disaggregate the index to try to understand the specific influence of its components.  
 
2.1 The Institutional Context Of Corporate Governance In The UK. 
Firms listed in the United Kingdom operate under a different corporate governance 
framework than either the types typical in mainland Europe and Japan, or the United 
States. The latter difference is not always noted because commentators often group 
together countries termed “liberal market economies” (LMEs) where firms tend to be 
listed  so that a thick market exists for shares and whole companies. These are 
contrasted with “coordinated market economies” (CMEs) characterised more by 
                                                 
3
 Other important issues concern the role of property rights in inducing effort and commitment (Aiguilera and 
Jackson 2010). Two broad-reaching studies of corporate governance and its effects on innovation are Belloc 
(forthcoming 2012) and Driver (forthcoming 2012). Belloc identifies three sub literatures dealing with the links 
between innovation and governance: principal-agent, “incomplete contracting” and “organisational control 
theory”. He relates these to three discourses in the literature on the effects of ownership, financial systems, and 
human resource management so as to identify a large number of competing hypotheses and corresponding 
evidence. Driver classifies the literature into six theories : principal agent; transactions cost; resource-based 
theory; property rights; adaptation; and varieties of capitalism discussing both the main hypotheses, their 
implications for innovation, and the empirical evidence.   
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block-holdings by other firms, banks or families and where it is more difficult to buy 
control of firms. The dichotomy refers not just to systems of corporate governance 
but to a co-evolved  system of , finance, firm-level incentives, industrial relations, 
education and inter-firm collaboration. Under these conditions, concentrated 
holdings, typical of  CMEs, are said to permit  a longer-term planning horizon, while  
longer tenures for employees underpin investment in training (Hall and Soskice 
2001). This simple dichotomy between LMEs and CMEs is not without merit. It can 
be used to illustrate how countries such as the UK differ radically from others such 
as Germany on issues such as intra-industry cooperation in innovation (Love and 
Roper 2001). But the situation is more complex because there are also serious 
differences between countries within each camp and in particular within the two most 
important LMEs, the UK and the US (Tylecote and Ramirez (2006); Mallin, 2007;  
Bruner 2010). Two such distinctions will be identified here because they have a 
bearing on innovation. First, the United States, having flirted with a system that 
permitted easy hostile takeover in the 1980s recast that approach that by permitting 
takeover defences in most states from the end of that decade ( Bertrand and 
Mullainathan 2003; Tylecote and Visintin 2008). By contrast in the United Kingdom it 
is harder for management to fend off a hostile bid. This has implications for the 
horizon length with which UK managers plan for the future. A second difference is 
the much greater size of the US financial market relative to the UK which permits 
economies of scale in financial monitoring of technology. Financial analysits  in the 
US have greater  access to more detailed information on technological firms than is 
the case in the UK (Tylecote 2007). This issue has been repeatedly identified as a 
block on long-term provision of finance for R&D.4   
 
The lack of information matters especially in industries where external finance is 
needed to fund future growth. If managers, with their superior inside information, are 
prevented by stockmarket pressure from acting autonomously , it is necessary for 
the investors themselves or their board representatives to make informed judgments. 
But the ownership structure in Britain militates against this, at least in its present 
form, since voting blocks rarely exceed 10% of shares and there is thus a “free-rider” 
problem as who would bear the cost of close oversight and intervention. During the 
                                                 
4
 Early mentions of this problem include the Innovation Advisory Report (1990). A systematic account of the 
issue is contained in Tylecote and Visintin (2008). 
8 
 
sample period, UK insurance and pension firms owned almost exactly one third of 
the shares of UK listed companies. A further third was owned by foreign interests 
with the remainder split between individuals, non-financial companies, banks, 
investment trusts, hedge funds  and public bodies.5 Exceptionally, with large UK 
listed companies, a hedge fund or sovereign wealth fund may intervene pro-actively 
to change strategy in companies that they part own. But the big players such as 
pension funds and insurance funds, despite government entreaties, have mostly 
resisted pressure to engage in this process and prefer to maintain an arms-length 
relationship. 
Thus, the example of the UK provides an interesting laboratory for examining the 
influence of corporate governance on innovation.  Of the liberal market economies it 
comes close to being a polar case where liquidity matters for investors rather than 
long-term commitment. As noted in Brunner (2010),  “...the UK corporate governance 
system is substantially more compatible with theories emphasizing shareholders’ 
interests that the US corporate governance system is.” (P.610). Thus, UK managers 
have to make innovation decisions knowing that their company can rapidly change 
ownership and knowing that investors are likely to respond to disappointing results 
by a quick sale rather than informed pressure for a change of strategy. The question 
we explore is whether the formalisation of shareholder orientation in the UK 
corporate governance code  - that was increasingly accepted by all major companies 
during our sample period -  had a general effect of encouraging or discouraging 
investment in R&D.  
 2.2 Testing For The Effects Of Governance On R&D 
Our intention in the paper is to test the channels of influence from corporate 
governance to R&D spending. The elements of good governance consist of 
measures to align the interests of owners and managers, viz: board independence 
from executive management, transparency and ease of achieving oversight, and 
incentives. (Higgs 2003).  
 
                                                 
5
 The figures are from Mallen (2007) citing ONS data for 2004. These ONS data have recently been criticised 
for inadequate sampling methods, but apart perhaps from overseas holdings, any revisions are unlikely to affect 
the general pattern noted above. 
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Irrespective of whether governance procedures have these hypothesised effects, it is 
undeniable that company boards have become obliged to pay attention to such 
issues.  As noted by Lysandrou and Parker (2011), the practice of collapsing the 
multiple dimensions of corporate governance into a summary statistic of an optimal 
structure of governance is now accepted by regulatory authorities as well as asset 
managers  which explains “why corporations are under pressure to conform to that 
optimal structure”  (p.2). We term this process the conformity channel of influence 
from governance to R&D because it is concerned with relieving finance constraints 
through making companies acceptable to investors (Tirole 2006; Hall and Lerner 
2010).  
 
We are also interested in isolating any direct effect of governance changes on R&D 
that may arise from specific individual features of governance rather than simply 
from the extent of compliance with the standard checklist. The argument here is that 
some specific features of governance may be conducive to innovation, even if the 
overall index is not. We term this process  the direct effects channel of influence  and 
we investigate it by disaggregating the overall indicator of governance.  Of course, 
just as the overall index may result in  positive or negative  effects on  R&D , the 
same may be true of some of its components. Again this is largely an empirical 
matter. 
 
In the remainder of this paper we set up a specification and report empirical results 
on the link between governance and R&D. Section 3 outlines the theoretical 
foundation of R&D investment and shows how governance may be expected to 
modify the basic model by setting out a number of hypotheses. A number of 
hypotheses are presented. Section 4 details the specification used in testing these 
hypotheses, along with brief accounts of existing evidence. The sample and data 
sources are then outlined in Section 5, This is followed by a discussion of the results 




3. THEORIES OF R&D INVESTMENT 
A good general understanding of the drivers of firm-level R&D expenditure has been 
available for some time (Saviotti 1987; Cohen 1995; Crepon et al 1998) but further 
progress has been slow; studies of aggregate R&D expenditure and its determinants 
are now relatively rare in the field of innovation studies. In part this may be explained 
by disagreement over its adequacy as a measure of innovation, or even of 
innovation effort (Pavitt 2005). Some estimates suggest that in the UK, R&D 
accounts for only about half of all innovation inputs (Bulli 2008; Roper et al 2008). 
Even so this is still substantial and it of some concern that variation in R&D intensity 
of UK-owned firms has not yet been well explained (Bulli 2008;Rogers 2006). 
Given that questions of appropriability and uncertainty are significant features of 
R&D it is only natural to consider finance as a possible constraint on R&D and to 
consider whether routines of good governance could lessen such constraints and 
indeed ameliorate any general agency concerns that might affect the R&D decision. 
In recent papers, it has been suggested that further progress may depend on 
integrating the theory of R&D investment with models of agency and financial 
constraints (Hall 2002; O’Sullivan 2005; Lhuillery 2011).  
R&D is characterised by specific features. First, assets are intangible (and thus 
largely sunk or irreversible); second, its gains are difficult to appropriate in full unless 
protection is available through patents, secrecy,  or unique complementary assets; 
and  third, its cash flows are both long-term and unusually risky.  Nevertheless, 
although R&D is a distinct activity it has similarities with capital investment and may 
thus be modelled similarly. For example, although fixed investment is surely tangible 
it is also highly irreversible at least in manufacturing sector (Asplund 2000). In regard 
to spillover effects, these are not confined to technology given that market 
externalities are often present (Porter 1985). 6   Nor is risk uniquely related to 
research intensity, as may be observed by any casual observation of high Beta 
stocks. Many other claims for the specificity of R&D such as its strategic importance 
and its two-faced role in being both performative and informative also apply to any 
tangible investment that offers option value (Cohen and Levinthal 1989). Indeed the 
                                                 
6
 Nor are the methods of appropriating profits from innovation so different as for other investments. Cohen et al 
(2000) confirm that secrecy, lead time and complementary activities are key in most industries. 
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notion that R&D capital stock acts as a sponge for ideas that can be released when 
market conditions are ripe has a close correspondence to the idea of excess 
capacity as a strategic reserve for companies. It thus seems reasonable to argue 
that the standard theory of investment may provide a good starting point for R&D 
estimation, as long as the model incorporates irreversibility and uncertainty 
(Mairesse et al 1999; Bond et al 2003). Indeed the somewhat surprising conclusion 
of this literature is that differences in the estimated structural relationships  - apart 
from adjustment speeds - are larger across countries than across classes of 
investment. 
 
The modern theory of investment under uncertainty is a development of Tobin’s Q-
theory where a signal for profitable investment is given when the marginal addition to 
firm value accruing from the investment exceeds the incremental cost (Summers 
1981). Under restrictive assumptions, this is equivalent to a modified accelerator 
model with a cyclical term, driven by sales (Driver et al 2005). The dependence of 
R&D on sales corresponds to the empirical literature (Saviotti 1987;Stephan 2004). 
Other industry-level evidence for the UK confirms that output or value added is the 
main explanatory variable for R&D (Vecchi et al 2007; Becker and Hall 2009). 
  
 R&D investments involve uncertainty and irreversibility, a combination that is often 
analysed using a real options framework. The option to wait (where uncertainty and 
fixed cost feature) leads to a higher hurdle rate for R&D (Dixit and Pindyck 1993; 
Mcdonald 1998; Chirinko and Schaller 2009). But the option to follow on (that 
characterizes some R&D sectors) reverses this conclusion, as does situations where 
quick expansion of supply is difficult following a demand shock (Smit and Trigeorgis 
2004; Driver et al 2008). For technologically advanced investments and R&D 
expenditure, both optionalities (irreversibility and expandability) are likely to come 
into play and since the conditions in which either one might dominate are hard to 
specify, the implications for a model of R&D are unclear. .  
 
Nevertheless, the very fact that private information is important to assess the hurdle 
rate for R&D gives some fresh insight into how to model it. Real options analysis 
complicates the signal for R&D investment not just for the econometrician but also 
for those charged with assessing, monitoring and overseeing such investments i.e. 
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the board of directors, analysts, rating agencies, credit providers and ultimately the 
investors themselves. In effect the complication produced by real options analysis 
creates an information asymmetry and information advantage for managers vis a vis 
the Board and magnifies any agencies problems that normally characterise long-run 
corporate decision-making. Real options theory thus justifies an investigation of the 
effects of governance procedures directed at resolving principal agency issues. If 
asymmetric information between managers and investors is severe, as in many R&D 
intensive businesses, investors will tend to rely on general assurances that 
companies are complying with good practice. Thus the financial conformity 
hypothesis – that investors pay attention to general corporate governance indices - 
will be important to test. 
 
3.1 Setting Out The Hypotheses 
3.1.1 The conformity channel.  Before identifying the hypotheses, we need first to 
specifiy the directional effect of the conformity channel of influence that relates to 
how governance reassures investors. We argue below that enhanced governance 
will, according to the standard principal agency view, increase R&D because 
investors will be assured that managers are not shirking. Since R&D usually has 
lengthy pay-back periods, involves the uncertain role of absorptive capacity building, 
and is characterised by high idiosyncratic risk, there is an a-priori expectation of 
underinvestment by managers that governance needs to assess (Eisenhardt 1998; 
Hall 1990; Cheng 2004). This is particularly so where managers are highly mobile or 
have short tenures (Palley 1997), or where earnings management is practised 
(Bushee 1998). 7  Our maintained assumption therefore is that R&D is characterised 
by underinvestment to begin with, implying a positive relationship between 
governance variables and R&D activity. We therefore test: 
H1: Greater levels of governance induce more R&D spending. 
 
As noted in Hall (2002), existing research is “fairly silent on the magnitude of these 
[agency] effects” (p.39) and by implication is equally silent on the power of any 
corresponding governance solutions. It is not even a priori clear that there will always  
                                                 
7
 R&D managers do appear to have short tenures (Lerner and Wulf 2006). Empire building with R&D might 
conceivably  be explained by entrenchment where managers are specialised but it seems unlikely that R&D 
decision-making is decentralised to the level of specialised managers and in any case managers may more easily 
defend themselves by expenditure on marketing or diversification (Krafft and Ravix 2005, Kor 2006). 
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be a positive effect of governance on R&D. The possibility of perverse effect of “good 
governance” on uncertain investments through discouraging autonomy has also 
been noted in the literature (Baysinger et al 1991; Burkart. et al 1997; Lazonick 
2008). We are thus led to consider an alternative hypothesis against which H1 may 
be compared: 
HA1: Greater levels of governance induce less R&D spending. 
 
 Next, we consider a different way of testing the conformity channel by looking for a 
possible interaction effect between the cash flow (finance constraint) and the 
corporate governance index (CG). Under asymmetric information between managers 
and investors, R&D projects will primarily be financed from internal funds according 
to the “pecking order theory” (Frank and Goyal 2008). Where there are more 
profitable opportunities than can be funded internally, this may lead to a finance 
constraint, indicating a potential positive effect of free cash flow on R&D expenditure. 
 
Arguably, the effect of incidence of financial constraint would  disappear in well-
governed firms, since investors would be reassured, thus attenuating the “lemons” 
problem (Stein 2003). Figure 1 shows a simple demand and supply diagram of funds 
for R&D where a flat portion of the supply curve turns upwards at the point where 
external funds are called upon. If the demand for R&D funds intersects the rising 
portion of the supply curve, the return to R&D will have to be higher to justify the 
cost. Governance can have several effects in this model. It can translate the demand 
curve to the left or right depending on whether it depresses or encourages R&D 
directly. At the same time, in relation to the conformity channel, good governance 
can flatten the supply curve if information and transparency reassure investors. To 
our knowledge this interactive effect of governance and cash flow on R&D has not 
previously been investigated in R&D investment studies. However, the interpretation 
of financial constraints in investment and R&D studies has continued to be a source 
of controversy in the literature. 8. We thus test the hypothesis: 
                                                 
8
 The evidence in favour of a cash flow effect for R&D is mixed (Bond et al 2003). Previous results 
supportive of a link include Hall (1992; 1999); Himmelberg and Peterson (1994) and  Mulkay et al 
(2001). Cincera and Ravet (2010) suggest that financing constraints on R&D have appeared in 
Europe, but not the US since 2000, whereas earlier work by Hall (2002) suggested a higher cash flow 
coefficient for the US and UK than elsewhere. A related finding in Bond et al (2003) suggests that 
cash flow is important for the decision to do R&D but not its intensity. Malmberg (2008) finds 
significance for cash flow on Swedish pharmaceutical company R&D at industry and firm levels using 
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H2: Greater levels of governance operate to reduce any financial constraints for R&D 
intensive firms 
 
3.1.2 The direct channel.  So far we have been concerned with the conformity 
channel according to which the importance of governance is to give assurance to 
investors through compliance with a generally accepted code of practice. This may 
not be the only channel through which governance operates, Even within a standard 
principal agent view it is possible to regard some aspect of governance principles as 
more relevant or sensible than others. Indeed the available literature indicates 
considerable heterogeneity in results. Given these conflicting findings, we test 
individually the sub-components of the CG index, specifically: 
H3 Individual components of a general government index contribute different 
directional effects to the index itself. 
 
We also address in this paper the influence of ownership form on R&D, a feature 
related to, but somewhat distinct from governance. The concentration of shares 
owned by investors and who owns them are issues that can affect the ease with 
which direct oversight of managers can be coordinated. Block ownership (usually 
defined as a holding greater than 5%)  is one attribute that may encourage more 
oversight (Bushee 1998). The same may be true of some types of institutional 
ownership. Finally, ownership by executive management such as the CEO may be of 
particular significance since it not only gives management a stake in the company 
but allows the arguably better informed members of the board to display more 
independence in relation to other members.Our final hypothesis is thus: 
H4 Greater Managerial Ownership and Institutional Ownership induce more R&D 
spending. 
                                                                                                                                                        
a two year lag and a long data series over four decades. Ughetto (2008) finds an effect for Italian 
SMEs;  Canepa and Stoneman (2008) report a similar effect for UK firms for a broader category of 
innovation. Hyytinen and Toivanen (2005) identify a financial constraint by investigating the effect of 
R&D subsidies. However Vecchi et al (2007) find no evidence for interest rates or current profits in 
their industry-based analysis of the UK. Rogers (2006) infers a lack of financing constraints for large 
R&D spenders in the UK on the basis of comparative international R&D productivity. Brown et al 





4. MODEL SPECIFICATION 
 
Following the general discussion of R&D determinants in the previous section, we 
embed a target ratio for R&D-to-sales intensity in an adjustment model with dynamic 
effects that capture the error-correction path of R&D expenditure. Such an approach 
has typically been employed in investment studies (Mairesse et al 1999; Bond and 
Van Reenan 2007) and has also been used in studies of R&D (Bond et al 2003; 
Becker and Hall 2009). It has the advantage of making it more likely that the 
dependent variable is stationary, as investment is normally thought of as integrated 
of order one. It has the further advantage that by modelling explicitly the cyclical 
adjustment, it prevents this from being confounded with cash flow (Harhoff 1998).9 
 
Writing        for RDI intensity measured as the ratio of R&D to sales for firm   at 
time   
 
                                                                                  ...(1)                                                               
 
 
The basic model is supplemented by a number of variables. In regard to size of the 
firm itself, it has been argued since Schumpeter (1942) that large firms may have 
several advantages that encourage R&D spending including better access to capital, 
greater economies of scale and more complementarities. Set against this, large firms 
may encounter loss of managerial control in resource allocation and they need to 
rely on lower power incentives (Cohen 1995). Hence the role of size is ambiguous 
and may be more relevant to the decision to do R&D rather than its intensity (Bulli 
2008). Nevertheless, size is also associated with process innovation according to the 
innovation life cycle hypothesis and such innovation may be more R&D intensive 
(Reichstein and Salter 2006). Size is sometimes interpreted as a proxy for market 
power or an inverse indicator of product market competition, but again the theoretical 
impact on innovation impact is ambiguous (Aghion et al 2005; Vecchi et al 2007) 
There is also an argument that size proxies for indicators of absorptive capacity and 
                                                 
9
 We regard the Euler framework as unsuitable for the R&D context; the adjustment costs are 
discontinuous in the presence of real options that are likely to characterise irreversible investment and 
we do not have good firm-level data to model these expected disequilibria. 
16 
 
the ability to enter into collaborative arrangements. We include size in our regressor 
set, mindful of these ambiguities.  
 
Public subsidies may also be argued to affect the private expenditure of R&D. One 
issue is whether direct grants crowd-out (or crowd-in) private expenditure either at 
the level of the firm or economy. The study by David et al (2001) and the meta-study 
by Garcia-Quevedo (2004) were inconclusive. Guellec and Van Pottelsberghe de la 
Potterie (2003) found positive rather than negative effects except in the case of 
defence subsidies for 17 OECD countries; Gonzalez and Pazo (2008) found no 
indication of crowding out in the case of Spanish manufacturing firms. In our 
specification, only time-varying effects need to be included which is of interest 
because temporary subsidies tend to be ineffective.10 In Section 6.1 we report a split 
sample excluding defence-related firms who are most likely to receive subsidies. 
 
Clearly there are many issues that influence R&D that are not expressed in (1) as 
they are subsumed in the fixed effects    term that includes all non-time varying 
determinants, such as the general appropriability conditions and technological 
opportunities. 11  A reasonable question to ask is whether, in any panel of high 
technology firms, these effects can really be taken as fixed given that the boundary 
of the firm may alter over time. Our answer here is that the time frame is just six 
years and that we later report ( Section 6.1) split sample results which seek to 





                                                 
10
 Another issue relates to the tax credits for R&D announced for large firms in 2001. The credit 
operates in respect of incremental R&D performed in the previous two years. As the policy extension 
was well telegraphed to companies it may be expected to have had an effect over our entire sample 
period, though it corresponds to only a fraction of a percent of the cost of capital Any effect should not 
vary much across large firms because they are unlikely to be tax-exhausted (and because it is an 
incremental rather than a volume measure). The dynamic effects are, however, unclear as the 
incremental R&D for which credits are paid raise the threshold for subsequent claims (Bloom et al 
2001).Furthermore, the credit applies only to UK-performed R&D so its incidence is difficult to track. 
11
 Crepon et al (1998) found that market share variables displaced size in equations explaining the 
R&D stock, while variables such as diversification, and demand-pull and technology -push dummies 
were sometimes significant. The latter were obtained from innovation surveys which we are unable to 
use as our sample concerns global activity. 
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4.1 Adapting The Basic Model To Test Hypotheses 
Under H1 we expect increased governance to result in more R&D.12 Accordingly, we 
include in the specification a standard index of good governance (CG) to test its 
effect on R&D intensity, an index of financial constraint (cash flow CF) and also a 
control for size (SZ). We do not expect a levels effect for the cash flow variable as it 
represents a constraint on adjustment. This results in equation (2).  
 
                                                                     
                                                                                                     ....(2)                                               
 
Hypotheses H2, H3 and H4  require slight modifications to (2) that amount to the 
inclusion of an interaction term between CG and ΔCF (H2); the disaggregation of CG 
(H3) and the addition of ownership variables (H4). 
 
 4.2 Definition Of The Corporate Governance Index (CG) 
As the contribution of corporate governance is at the heart of this paper we indicate 
here how the index CG has been constructed. This follows the conventional 
approach (Gompers 2003; Black et al 2006) in that the index comprises both 
structure and procedures of the board of directors, and the manner of executive 
compensation.  
 
Boards are argued to be more effective if they are small, have separate people as 
CEO and Chair, and have a degree of independence from executive management. 
We include an indicator of each of these in our index with the added feature that in 
regard to independence we distinguish bare compliance - which is equality of 
executives and non-executive (independent) members – from a more pronounced 
independence stance where the independents have a strict majority. We do this 
because there is clustering by firms at the conventional level of 50% independents. 
 
The CG index comprises six components (four board variables and two for 
compensation) as follows: 
                                                 
12
 The maintained hypothesis here is that managers are overcautious or myopic in respect of R&D 
(Hall 1990). Hall and Lerner (2010) cite evidence that anti-takeover measures that increase 
managerial security either increase or do not decrease R&D. 
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Board size: dummy variable =1 if board size < 12 
Separation of powers: dummy variable =1 if CEO and Chair of  Board are not the 
same person. 
Observance of Higgs (2003) code of practice: Dummy variable = 1 if at least 50% 
independent or non-executive. 
Independent Control: dummy variable = 1 if a clear majority of directors are 
independent or non-executive. 
The index contains two other dummy variables for compensation where the intention 
is to identify different types of high-powered compensation in relation to basic pay, 
with the most high-powered incentive being payment in stock and options whose 
value is generally contingent on future firm performance. 
Bonus: Dummy variable =1 if bonus component in total compensation > 20% 
Stock & Options: Dummy variable = 1 if stock and options component in total 
compensation > 30% 
Note: The above critical values for compensation correspond to the average 
percentages for large UK companies reported in Conyon et al  (2009). 
 
The CG index is then formed as a simple sum of zero-one dummies over the six 
components of the above list. Our index is a stripped down version of some others in 
the literature such as Black et al (2006) given that our sample of large firms displays 
less heterogeneity than in many studies so that all the firms in our sample have for 
example, a remuneration and an auditing committee. The index is constructed 
separately from ownership variables that are introduced when discussing the results 
for Hypothesis H4 in Section 6.4. 
 
4.3 Previous Results Relating R&D To Governance And Ownership 
For managerial incentives Wu and Tu (2007) using Computstat data for large 
research intensive firms find that CEOs high powered compensation can increase 
R&D under high growth or with high slack, but that does not extend to other types of 
incentive pay. This limited result is consistent with Eng and Shackell (2001) and 
Devers et al (2000) who find an effect on CEO risk-taking but only for some forms of 
equity-based pay.  Lhuilery (2011) using a large sample of French firms does not 




 In relation to independents on the board of directors, much of the evidence does not 
support a positive link with R&D. Hill and Snell (1988) and Baysinger et al (1991) 
using Fortune 500 samples find negative relationships, while David et al (2001) finds 
no significant moderating influence of outsider executives on a positive role for 
institutional investors. Kor (2006 ) in a US study finds no effect for outsiders on R&D 
intensity or in countering the tendency of long-tenured management teams to avoid 
investment risk for uncertain long-term projects. Hoskisson et al (2002) finds that 
outsiders on the board is associated with acquisitions rather than internal innovation. 
Lhuillery (2011) finds some support for a positive effect of governance principles on 
R&D intensity , though not for board composition. The same is true of Lacetera 
(2001) for a study of the US pharmaceutical industry . Other issues such as board 
size have found more consistent results with a presumption in favour of efficiency for 
smaller boards, often with an upper limit of 12 being suggested following the classic 
US study by Yermack (1996).  Guest (2009) confirms that large UK boards suffer 
from coordination difficulties but his results suggest that this effect is reduced for 
firms with high R&D intensity, while Cheng (2008) finds a positive effect on R&D 
spending from larger boards in US technology firms. 
 
The literature on ownership also contains conflicting results. There is some evidence 
of a positive effect on R&D of concentrated or institutional holdings (Hill and Snell 
1988; Smith et al 2001; Lee and O’Neill 2003;  Munari and Sobrero 2003). Aghion et 
al (2009) find a  small and fairly weak effect of institutional ownership on R&D but  
they argue that the main effect of governance is on the productivity of R&D.  The role 
of CEO ownership is also controversial with some claiming it has an important 
incentive effect, or acts as reassurance for investors, while others argue the reverse 
- that it acts as as form of entrenchment. Of course, since entrenchment is often 
indistinguishable from autonomy there is yet another dimension to consider, raising  
the possibility of a non-linear inverted U-share relationship between CEO ownership 
and R&D spending (Ghosh et al 2007). 
 
5. SAMPLE AND AND DATA 
Governance operates at the level of the jurisdiction of national corporate law and 
stock exchange listing so our interest is in the total expenditure of UK-based 
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companies, not in expenditure on UK-performed R&D. The reason for limiting our 
sample by size and jurisdiction is partly one of data access. Data is required for each 
firm not only for the standard determinants of innovation expenditure but also for a 
range of governance characteristics; this is time consuming and expensive to collect 
and each data-point needs to be checked carefully for anomalies. The restriction to 
UK-listed firms confines the analysis to one “variety of capitalism” though it should be 
stressed that large UK firms are international in terms of reach and perform R&D 
increasingly abroad (BERR 2008). Additionally, this narrow focus simplifies the 
interpretation of the analysis. Previous work has shown for example that different 
jurisdictions have oppositely signed effects of governance variables on innovation, 
as with the role of institutional ownership on innovation in the USA versus Japan 
(Lee and O’Neill 2003) or Europe versus the UK (Munari et al 2010): the implication 
is that corporate governance works differently in different environments. In our view 
the corporate governance framework that affects important decisions such as R&D is 
that corresponding to where the firm is incorporated; that is after all the level of 
enforcement through stock exchanges and national legislation. (Windsor 
2009).There is of course some variety in the degree of autonomy of foreign 
subsidiaries and there is a literature on how the exploitation of local country-based 
resources can fit with centralised power and decision-making (Birkinshaw 2001). 
One detailed case study of a UK-based multinational and its foreign subsidiaries 
showed that “only marketing, distribution and after-sales service” tends to be 
organised regionally with R&D and capital investment centralised (Krisetensen and 
Zeitlin 2005). The reason was attributable to its stock-based financing mode: 
“Nothing could be more important from the headquarters perspective...than to ensure 
that the City received a single coherent story...”  (p.141). While there may be 
exceptions to this pattern, for shareholder economies at least,  it seems likely that 
major strategic decisions are centralised, given the need to offer a disciplined 
narrative that caters to investors in its financial base. This conclusion is also 
supported by survey evidence on whether global firms with multiple technologies 
centralise their R&D (EIRMA 2000). 
Our initial sample comprised the top 100 UK manufacturing and service (excluding 
financial) firms, with the highest averaged R&D expenditure in the period 2000-2005. 
We had to exclude some firms because of missing values for R&D expenditure. For 
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example, some firms showed a change from zero R&D expenditure to a positive 
expenditure in the course of a single year. This might be because the firm had not 
performed R&D for some time; however, this is unlikely based on the fact that the 
sample includes the top R&D spenders, and means that zero values are likely to 
result from non-recording. In line with Bond et al (2003), we excluded the set of 
observations with missing data from the sample.  
Our final sample consists of an unbalanced panel of 91 firms and 546 year 
observations, for the top R&D spenders in the UK. Manufacturing firms predominate, 
with some 70% of firms. The predominant sectors are Electronic and Electric 
Equipment with 12 firms (about 13% of the sample) ,Software and Computers with 
13 firms and Pharmaceuticals with 8 firms. The sample accounts for about 76% of 
total R&D expenditure by UK business (BERD). 
 There are some  positive arguments in favour of our sample restriction. The large-
firms that we analyse not only perform the vast bulk of total R&D but have also been 
subject to most scrutiny and pressure in terms of their governance procedures 
(Higgs 2003). While there are other important R&D policy issues in regard to small 
firms’ participation and sustained efforts in innovation, we believe that the 
governance influence will be best captured in our restricted sample if it is indeed of 
importance. Given our focus on top spenders, we do not, in this paper, deal with the 
decision of whether or not a firm performs R&D in the first place. Thus our results are 
to be interpreted as conditional on the firm being R&D active. 
Data on R&D, sales and cashflow were downloaded from Datastream.13 R&D 
intensity is calculated as the ratio of R&D to Sales. Figure 2 shows the mean R&D 
intensity over the sample indicating that the period contains substantial time 
variation. Size is measured by number of employees. The Cash Flow variable is 
based on the Datastream data extracted from company annual reports, where it is 
defined as the value of net income, plus amortization and/or depreciation, less 
change in working capital, less capital expenditure.  However, because R&D 
                                                 
13
 The R&D data in datastream (code 01201) captures firm expenditure and follows the Frascati Manual in 
including  basic & applied research; and development. It excludes contributions by government, customers, 
partnerships or other corporations to the company's research and development expense. Other Datastream data 
sources are for sales (01001);employees (07001);free cash flow (04201);taxes paid (01451); capital expenditure 
(04601); net profit before taxes (01401). 
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expenditures are expensed and this reduces the overall tax paid, this variable is 
transformed as in Hall (1992) and (Malmberg 2008) into profit before allocations and 
tax, plus depreciation, minus tax, plus after tax R&D expenditure. 
Data for the corporate governance variables were obtained by purchased access to 
the Manifest global proxy governance and voting service database. Each of the 
components of the CG index as well as the ratios of share ownership by large 
blockholders. and by the CEO, were calculated from these data. Note the upward 
trend in the mean of the CG index over the sample period shown in Figure 3 that 
confirms that there has been significant variation in governance norms over the 
sample period in a way that allows panel data estimation to be applied. The period of 
our sample lies between the dot-com crash and the beginning of the global financial 
crisis, a period that was characterised by intense (exogenous) pressure for reform of 
corporate governance. 
 
6. RESULTS AND INTERPRETATION 
 
 
The results for Hypotheses H1 and HA1 are shown in Table 1, where the interaction 
term between governance and the cash flow term is excluded.. Results for H2 are in 
Table 2 where the interaction term is included.  In both tables we report a standard 
fixed effects (FE) model, which however will suffer from biased coefficients given the 
short sample and the presence of a lagged dependent variable. The bias may be 
less serious on account of the low value of the coefficient on the lagged dependent 
variable and the presence of several other regressors; nevertheless it is appropriate 
to use alternative estimators for this case and we report the Arellano and Bond one-
step robust GMM estimator. This is shown in the table as GMM. A further variant that 
uses additional instruments (in Table 2) is shown as GMM1.14 
 
[TABLE 1 HERE] 
                                                 
14
 The use of GMM is strictly required where the lagged dependent variable introduces Nickell bias (Arellano 
2006). Nevertheless, the Fixed Effects results are useful for comparison and in the tables reported here, they 
give broadly similar results. The use of Random Effects models is ruled out because the sampling process is 
non-random. The GMM1 estimations augment the usual instrument set of lagged endogenous variables with 
industry averages for the endogenous variable CG to capture industry heterogeneity that may infleunce the firm 




6.1 Hypotheses H1 and HA1 
Turning first to the first table, it may be seen that the basic R&D model in the first two 
columns (excluding governance and cash flow variables) is validated with high 
overall significance and no problems with the diagnostics. In all cases, significance is 
found for the error-correction term in sales and a positive and stable dynamic effect 
is observed. The error- correction term is close to (minus) unity in the GMM 
estimates suggesting a rapid feedback to departure from target R&D intensity. The 
coefficient on size is positive as expected and insignificant.  The remaining columns 
report the effect of entering the governance variable and cash flow variables. The 
governance variable in levels is significantly negative in all specifications (FE and 
GMM) where time dummies are omitted, suggesting that there is a long-run negative 
effect of  governance on R&D. Thus there is no support for H1 but the contrary 
hypothesis HA1 is not rejected. This is consistent with the views of those who have 
argued that governance can have contradictory or perverse effects e.g. through 
reducing managerial security or discouraging the build-up of hard-to-measure real 
options (Palley 1997 Burkart et al 1997; Lazonick 2008; Hall and Lerner 2010; Van 
Pottelsberghe et al 2011). Thus, our interpretation here is that  governance is shifting 
the demand for R&D funds leftwards in Figure 1. We cannot rule out the possibility 
that the negative coefficients for the governance variable could represent an effect 
whereby firms are responding to empire-building tendencies in respect of R&D. 
However, we have argued earlier that this is unlikely given the a-priori view that R&D 
is characterised by underinvestment. Rather, we would interpret any effect here as in 
line with previous work such as (Baysinger et al 1991) who suggested that top 
executives “ may be more willing to invest in risky R&D projects if they...are less 
dependent on the judgement  and evaluation of outside directors (p.211). To check 
for non-linearity we entered an additional quadratic term in CG without obtaining 
significance. Furthermore the Ramsey RESET test, executed for the fixed effects 
estimation in column (3) results in F(3,288) =0.18 and thus indicates no problem of 
mis-specification and in particular no problem due to non-linear functions of the 
variables being omitted. 
 
Table 1 also reports estimates that include time dummies in columns (5) and (6). 
This is done to check for stability in the coefficients; such dummies with differenced 
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equations imply shifts in growth rates. Our main interest here is in whether the 
equation coefficients are broadly stable. Most of them are, though the magnitude and 
significance of the CG terms fall, probably reflecting  co-movement of CG across 
firms  due to the compliance pressure exerted by investors over the sample period 
(Temple et al 2001). However, most of the time dummy terms are not individually 
significant and an exclusion test for them in shows only marginal significance for the 
whole set  (P=0.041 for coumn 5). Given that the Sargan test is acceptable at the 1% 
level and fails only marginally at the 5%, and that there are no problems with 
autocorrelation, it is reasonable to regard the results without time dummies as 
acceptable (Arellano 2006). 
 
A further test of robustness was carried out with a split sample. As with any panel of 
high technology firms, the question arises whether the boundary or nature of the firm 
can be regarded as stable given that technology will allow a shift in ownership and 
size and possibly product and process orientation. It is extremely difficult to deal with 
this but we approached it as follows. We obtained data on all deal activity affecting 
any of the firms in our sample, using the Zephyr database, excluding any small deals 
less than £10m. We then combined data on acquisitions, disposals and mergers and 
normalised the total by each firms capital expenditure over the sample period. 
Ranking the scaled index of deal activity, we selected the top 10% (9 companies) 
which we proceeded to exclude from the sample on the grounds that they are the 
most unstable. The results confirmed those in table 1, with broad similarity in results 
and with the CG variables continuing to be significantly negative.  
 
We also carried out a split sample estimation for firms that are defence related and 
likely to be in receipt of public subsidies which we identified as firms in the 
Aerospace, Electronic & Electrical Equipment, and Fixed and Mobile 
telecommunication sectors. Excluding these 18 firms, we again obtained results very 
similar to those reported in Table 1,  and here with even stronger significance than 
before for the CG terms. 
 
6.2 Hypothesis H2 
In the results for Table 1 we found no significant effects from cash flow, in line with 
other studies for large firms (Brown et al 2009), although the coefficients are always 
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positive in line with expectation. We now  report on Table 2 results  where the role of 
corporate governance is seen as modifying the coefficient on the cash flow term in a 
new interaction effect.  
 
[TABLE 2 HERE] 
 
Table 2 results are somewhat similar to Table 1 in respect of the error correction 
term, which is again close to unity for the GMM estimates; the lagged dependent 
variable is also significant and not much different from the estimates in Table 1. We 
introduce an interaction term between the levels governance variable and the cash 
flow term, to test the argument that financial constraints are modified by governance. 
We find that the interaction term is negatively significant, implying that the cash flow 
effect (finance constraint) is eliminated for firms with more governance. The 
constraint is binding for a governance index less than approximately 1.6  which is 
just under a half of the mean for this variable. As with the results in Table 1, the 
terms in CG lose significance in the presence of time dummies, though the 
interaction term itself is strongly significant. To test the combined effects of the 
variables comprising the interaction term (with time dummies) , we performed a chi-
squared exclusion test for column (6) that showed the terms to be jointly significant 
(p=0.084). 
 
Arguably, the result above could reflect the hypothesised effect of good governance 
on reducing agency costs of external finance. However, it is hard to square with the 
failure to find any direct positive role for governance. An alternative explanation is 
that  an increased level of  governance breaks any link between R&D intensity and 
cash flow by raising hurdle rates for R&D in favour of increased dividend pay-out 
ratios (Lazonick 2008; Driver and Temple 2010). This implies that the demand for 
R&D finance falls as a result of board strategy, eliminating any constraint, though 
any improvement in the terms on which finance is available is irrelevant. Referring to 
Figure 1 the effect found here can be illustrated by increased governance causing a 
leftward shift of the demand for funds so that it intersects the horizontal portion of the 
supply curve where no finance constraint is binding. Our results here suggest 
qualified support for H2 but – given the lack of any positive CG effect - with a 




6.3 Disaggregated Results For Hypothesis H3 
The principal-agent hypothesis conjectures that closer attention to firms’ strategy and 
operations, occasioned by governance improvements should not only reassure 
investors but also take effect through the direct channel of better allocation of 
resources and better decision-making generally within the firm. Thus we investigate 
whether sub-indices of the overall governance variable CG have positive effects for 
R&D. 
 
The governance results for H3 are shown in the first three columns of Table 3, based 
on disaggregating the overall CG index. The first column shows the effect of using 
just the compensation component (termed CGX1). Here we find the directional 
influence is the same as for the total index, with significance obtained at the 10% 
level, The result implies that efforts to change managerial approaches by strong 
compensation incentives appear to result in reduced R&D.  
We also find perverse results for the board size variable (CGX2) in the second 
column where both the lag and the first difference term are significantly negative. 
Recalling that the variable here is a unit dummy for size less than 12 members, this 
implies that smaller size is actually detrimental to R&D. The third column tests the 
combination of separate CEO and the Higgs director independence requirement 
(CGX3). Here again we find the same directional effect as in the overall index 
implying a negative effect (at 5% significance) on R&D from the application of such 
procedures.15   
 
In Table 3, the coefficients of the basic variables from equation (1) are broadly stable 
in comparison to those in Table 1. The Sargan test for columns 1 and 3 indicates 
some mis-specification,  though for the board size result  it is acceptable at the 1% 
level. The mis-specification is not totally surprising given that we have no strong prior 
for the individual effects. The Sargan statistic  is not improved by the addition of time 
dummies and although it is possible that various interaction effects or non-linearities 
could resolve the issue we leave this exercise for future work with larger samples. 
Overall, these results  uniformly reject  Hypothesis 3 that the sub-indices effects are 
                                                 
15
 Interestingly we did not find that these on their own were significant from which we conclude that it is 
compliance with the governance indices and codes that is driving the results. 
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signed opposite to the main CG index. The results here are consistent with those 
observed in Van Pottelsberghe et al (2011) who observed a negative effect on R&D 
intensity for performance related pay systems, as well as for the overall corporate 
governance score. 
 
6.4 Hypothesis H4: Ownership Effects 
In columns (4) to (6) of Table 3  we report the effect of including indicators of 
institutional and managerial (CEO) shareholdings.Column 4 gives the results for 
block ownership, where the argument that blocks exceeding 5% of holdings enable 
more efficient oversight of firms is assessed in relation to the effect on R&D. Here we 
find a negative effect at the 10% level. It is of course true  that this merely represents 
an average effect  across quite varied types of block holding; a larger sample of firms 
would be needed to discriminate between various different types of block, or different 
types of institutional investor  according to their mandate or their form of dealing . 
 
 Columns 5 and 6  of Table 3 deal specifically with managerial ownership and here 
there does appear to be a significant positive effect on R&D. In these columns we 
use a 1% threshold for the ownership dummy variable because very few cases (only 
8%) exceed the 5% conventional threshold that is generally used for block 
ownership. To test the robustness of this link between R&D intensity and CEO 
ownership, we replaced the dummy variable by the actual percentage owned by the 
CEO. Again it was significantly positive. Overall,  the results in columns 5 and 6 are 
stable vis a vis those in Table 1 and the Sargan tests are acceptable. We did not find 
any non-linear effect for managerial ownership.  
 




Finance and governance are likely to influence R&D expenditure in complex ways 
and there is certainly no consensus in the literature as to the expected nature and 
strength of any effects. This paper has obtained a number of interesting results for 




Our first result is that there is no evidence at all of a positive impact of governance 
on R&D across any of the estimation SETS. Rather, there is evidence in favour of a 
negative effect of high levels of governance on R&D, an outcome that contrasts with 
the perspective of “good governance”, but which is quite in accordance with a long-
standing literature that argues for the importance of managerial security and 
autonomy if risky investments are to be sustained.  
 
There is no strong evidence for an unmediated effect of financial constraints on R&D 
in our sample. However, by introducing an interaction effect between governance 
and financial constraint we identify an effect whereby financial constraints are 
important but may be negated at high levels of governance. One obvious inference is 
to claim that governance is relaxing financial constraints through increased investor 
confidence. However this explanation is hard to square with the absence of a direct 
positive effect of the governance variable on R&D. An alternative explanation is that 
stronger governance lowers finance constraints by imposing a higher hurdle for R&D 
investment and reducing the “demand “ for R&D by firms. Put differently firms 
operating under strong governance may ration R&D expenditure so as to increase 
disbursements such as dividends or to divert expenditure to faster payback projects 
(Lazonick 2008; 2010; Tylecote and Ramirez 2006). This would be consistent with 
the observed interaction effect and also with a failure to find any positive direct 
impact of governance on R&D. 
 
The results for the overall index represent the effects occurring through investor 
pressure for conformity. Individual components of the index may have particular 
effects that are positive for R&D even if the overall index is – as observed-  negative 
for R&D. In our disaggregated estimation we did not find any such positive effects 
within the index. Nor did we find that block ownership such as large institutional 
holdings increased R&D but rather decreased it (at 10% significance).  We did, 
however, indentify one positive effect for R&D occurring through CEO ownership. 
The higher this is, the more R&D is performed. A positive R&D effect is also 
observed when CEO ownership reaches a threshold of 1% of the total. This 
managerial ownership effect seems likely to reflect the influence of independence or 
autonomy of the (informed) CEO in relation to the board, in addition to any incentive 






Statistics over firm-year observations 
 
Variable Mean Median Minimum Maximum Standard 
deviation 
R&D (£ ‘000) 112,560 13,152 1,610 3,136,000   385,769.1   
R&D intensity 
(%) 
8.31 4.05 0.08   198.08   16.81 
Sales (£ ‘000) 4,093,082   484,000   5,891 155,000,000   14,500,000 
CF(£ ‘000) 619,172.1 38,579.5 -30,6000 17,200,000 1,925,337 
CG 3.61 4 1 6 1.22 








Aghion, P.,  & Tirole, J. 1997. Formal and real authority in organizations. Journal of 
Political Economy. 105 (1), 1-29. 
 
Aghion, P., Bloom, N., Griffith, R., & Howitt, P. 2005. Competition and innovation: an 
inverted U relationship. Quarterly Journal of Economics, 120,  701-728. 
 
Aghion P., J Van Reenan and Zingales, L. 2009. Innovation and Institutional 
Ownership, NBER Working Paper 14769. 
 
Aguilera, R. V. and G. Jackson. 2010. Comparative and International Corporate 
Governance.  The Academy of Management Annals, 4 (1), 485 — 556. 
 
Arellano, M. 2006. Panel Data Econometrics, Oxford OUP. 
 
Asplund, M. 2000.  What fraction of a capital investment is sunk costs? Journal of 
Industrial Economics, 48,  287-304. 
 
Baysinger, B., Kosnik, R., & Turk, T. 1991. Effects of board and ownership structure 
on corporate strategy. Academy of Management Journal, 34,  205-214.  
 
Becker, B., & Hall, S.G. 2009. Foreign direct investment in R&D and exchange rate 




Belloc, F. 2012. Corporate governance and innovation: a survey.  Journal of 
Economic Surveys, doi: 10.1111/j.1467-6419.2011.00681. 
 
BERR. 2008. Supporting Analysis for ‘Manufacturing Strategy: New Challenges, 
New Opportunities.  Department for Enterprise and Regulatory Reform, Economics 
Paper No.2. 
 
Bertrand, M.& Mullainathan, S. 2003.  Enjoying the quiet life? Corporate governance 
and managerial preferences. Journal of Political Economy ,111,  1043-1075. 
 
Birkinshaw J. 2001. Strategy and Management in MNE Subsidiaries” in Rugman , 
A.M. and Brewer, T.L. (2001) The Oxford Handbook of International Business, 
Oxford University Press. 
 
Black, B., Jang, H., & Kim, W. 2006. Does corporate governance predict firms' 
market values?  Evidence from Korea. Journal of Law, Economics and Organization, 
22,  366- 413. 
 
Bloom,N., Griffith , R. & A. Klemm. 2001. Issues in the deign and implementation of 
an R&D tax credit for UK firms.  IFS Briefing Note No. 15. 
 
Bond, S.,  Harhoff, D.,  & Reenen, J. V. 2003. Investment, R&D and financial 
constraints in Britain and Germany. CEP Discussion Papers dp0595, Centre for 
Economic Performance, LSE. 
 
Bond, S., & Van Reenen, J. 2007. Microeconomic models of investment and 
employment. in: Heckman, J. and Leamer, E. (Eds), Handbook of Econometrics, vol. 
6: 4417-4498. North-Holland, Amsterdam.  
 
Brown, J. R., Fazzari, S. M.,  & Petersen, B. C. 2009. Financing innovation and 
growth: Cash Flow, external equity, and the 1990s R&D boom. Journal of Finance, 
64 (1), 151-185. 
 
Bruner, Christopher M. 2010. Power and Purpose in the 'Anglo-American' 
Corporation.   Virginia Journal of International Law.  50 (3) ,  Washington & Lee 
Legal Studies Paper No. 2010-2.  
 
Bulli, S. 2008. Business innovation investment in the UK. Science and Innovation 
Analysis, DIUS. 
 
Burkart, M., Gromb, D., & Panunzi, F. 1997. Large shareholders, monitoring, and the 
value of the firm. The Quarterly Journal of Economics, 112,  693-728. 
 
Bushee, B. J. 1998. The influence of institutional investors on myopic R&D 
investment behaviour. The Accounting Review, 73,  305-333. 
 
Calderini M & P. Garrone.  2003. Liberalization and the balance of R&D activities: an 
empirical analysis.  in Calderini M, P Garrone and M Sobrero (2003). Corporate 





Canepa, A., & Stoneman, P. 2008. Financial constraints to innovation in the UK: 
Evidence from CIS2 and CIS3. Oxford Economic Papers, 60 (4),  711-730.  
 
Casper, S. 2009. Can new technology firms succeed in coordinated market 
economies? A response to Herrmann and Lange.  Socioecomic Review,   7 (2),  
209-215. 
 
Cassiman B. & R. Veugelers. 2002. R&D Cooperation and Spillovers: Some 
Empirical Evidence from Belgium.  American Economic Review, 92 (4), 1169-1184. 
 
Cheng, S. 2004. R&D expenditures and CEO compensation. The Accounting 
Review,  79,  305-28. 
 
Cheng, S. 2008. Board size and the variability of corporate performace.  Journal of 
Financial Economics,  87(1),  157-176. 
 
Chirinko, R.S., & Schaller, H. 2009. The irreversibility premium. Journal of Monetary 
Economics ,  56 (3), 390-408. 
Cincera, M & Ravet,  J. 2010.  Financing constrains and R&D investments of large 
corporations in Europe and the US. , Science and Public Policy,  37(6),  455-466. 
 
Cohen, W. M., & Levinthal, D. 1989. Innovation and learning: The two faces of R&D. 
Economic Journal, Royal Economic Society, 99 (397),  569-596. 
 
Cohen, W. M. 1995. Handbook of the Economics of Innovation and Technological 
Change, chapter: Empirical studies of innovative activity: 182-264. Blackwell.  
 
Cohen, W. M.,  Nelson, R. R., & Walsh J. P. 2000. Protecting their intellectual 
assets: Appropriability conditions and why U.S. manufacturing firms patent (or not), 
NBER Working Papers 7552, National Bureau of Economic Research, Inc. 
 
Conyon, M.J. ,Fernandes, N., Ferreira, M. A., Matos, P. & Murphy, K. J. 2009 
The Executive Compensation Controversy:A Transatlantic Analysis presented at the 
Annual FRDB conference held in Cagliari (Italy) on the 29th May.. 
 
Coombs, R., Saviotti, P., & Walsh, V. 1987. Economics and Technological Change. 
Rowmen and Littlefield NJ. 
 
Crepon, B., Duguet, E., & Mairesse, J. 1998. Research, innovation, and productivity: 
An econometric analysis at the firm level. Economics of Innovation and New 
Technology, 7(3), 115–156. 
 
Crouch,  C. & Voelzkow,  H.  2009. Innovation in Local Economies, OUP. 
 
David, P.,  Hitt, M.,  & Gimeno, J. 2001. The influences of activism by institutional 




Demirag,  I.S. &  Doi. N.  2007. R&D management under short term pressures: a 
comparative study of the UK and Japan.  International Journal of Technology 
Management,  40(4), 249-277. 
 
Devers, C. E., McNamara, G., Wiseman, R. M., & Arrfelt, M. 2000. Moving closer to 
the action: Examining compensation design on firm risk, Organization Science, 
19(4),  548-566. 
 
Dixit A. and Pindyck R. 1993. Investment under Uncertainty. Harvester NY. 
 
Driver,  C. 2012. Governance, Innovation and Finance.  in T Clarke and D Branson 
(eds) Sage Handbook of Corporate Goverance, Sage Publications. 
 
Driver, C., Temple, P., & Urga, G. 2005. Profitability, capacity and uncertainty: a 
model of UK manufacturing investment.  Oxford Economic Papers, 57,  120–141. 
 
Driver, C., Temple, P., & Urga, G. 2008. Real options - delay vs. pre-emption: Do 
industrial characteristics matter?  International Journal of Industrial Organization, 26,  
532–545. 
 
Driver, C., & Temple, P. 2010. Why do hurdle rates differ from the cost of capital? 
Cambridge Journal of Economics; 34 (3), 501-523. 
 
EIRMA. 2000. Centralized versus Decentralized R&D: Benefits and Drawbacks.   
Working Group 56, EIRMA, France. 
 
Eisenhardt, K. M. 1989. Agency theory: An assessment and review, Academy of 
Management Review, 14 (1),  57-74. 
 
Eng, L. L., & Shackell, M. 2001. The implications of long-term performance plans 
and institutional ownership for firm's research and development investment.  Journal 
of Accounting, Auditing and Finance, 16,  117-139.  
 
Frank, M. Z., & Goyal, V. K. 2008. Trade off and pecking order theories of debt. In: 
Eckbo, E. (Ed), Handbook of corporate finance: Empirical corporate finance, Vol. 2, , 
Chapter 12, Elsevier.  
 
García-Quevedo, J. 2004.  Do Public Subsidies Complement Business R&D? 
A Meta-Analysis of the Econometric Evidence.  KYKLOS, 57(1), 87–102. 
 
Ghosh,  A., Moon, D. & Tandon,  K.. 2007. CEO ownership and discretionary 
investments.  Journal of Business Finance Accounting,  34(5-6),  819-6- 839. 
 
Gompers, P. A., Ishii, J., & Metrick, A. 2003. Corporate governance and equity 
prices. Quarterly Journal of Economics, 118,  107-155. 
 
Gonzales,X. and Pazo,C. 2008. Do public subsidies stimulate private R&D 





Greenhalgh C. Rogers M. 2010. Innovation, Intellectual Property and Economic 
Growth, Princeton University Press. 
 
Guest P.M. 2009.  The Impact of Board Size on Firm Performance: Evidence from 
the UK. The European Journal of Finance, 15 (4, June),  85-404. 
 
Guellec, D., & Van Pottelsberghe de la Potterie, B.,2003.  The Impact of Public R&D 
Expenditure on Business R&D. , Economics of Innovation and New Technology, 
12(3), S. 225–243. 
 
Hall, B. H. 1990. The impact of corporate restructuring on industrial research and 
development.  Brookings papers on economic activity: Microeconomics, Washington, 
DC.  
Hall, B.H. 1992. Investment and research and development at the firm level: Does 
the source of financing matter? NBER Working Papers 4096, National Bureau of 
Economic Research, Inc.  
Hall, B. H. 2002. The Financing of Research and Development. Oxford Review of 
Economic Policy, Oxford University Press,18 (1),  35-51. 
 
Hall, B. H., & Lerner, J. 2010. The Financing of R&D and Innovation, in Hall, B. H. 
and N. Rosenberg (Eds.), Handbook of the Economics of Innovation, Elsevier-North 
Holland. 
 
Hall P. & Soskice, D.  2001 Varieties of capitalism: the institutional foundations of 
comparative advantage., Oxford University Press. 
 
Hancke,  B. 2009. Debating Varieties of Capitalism: a reader, Oxford University 
Press. 
 
Harhoff, D. 1998. Are there financing constraints for R&D and investment in German 
manufacturing firms?  Annales d'Economie et de Statistique, 49-50,  421-456. 
 
Higgs, D. 2003.  Review of the role and effectiveness of Non-Executive Directors, 
DTI London. 
 
Hill, C., & Snell, S. 1988. External control, corporate strategy and firm performance 
in research-intensive industries. Strategic Management Journal, 9,  577-590. 
 
Himmelberg, C., & Petersen, B. 1994. R&D and internal finance: A panel study of 
small firms in high-tech industries. Review of Economics and Statistics, 76,  38-51.  
 
Hubbard, R. G. 1998. Capital-Market Imperfections and Investment. Journal of 
Economic Literature, 36, 193-225. 
Hughes, A. 2007.  Innovation policy as cargo cult: myth and reality in knowledge-led 
productivity growth.  CBR working paper 348, University of Cambridge. 
34 
 
Hyytinen, A., & Toivanen, O. 2005. Do financial constraints hold back innovation and 
growth? Evidence on the role of public policy.  Research Policy, 34,  1385-1403. 
Kafouros, M. I. 2005. R&D and productivity growth: evidence from the UK.  
Economics of Innovation and New Technology., 14(6),  479–497. 
Kor, Y. 2006. Direct and interaction effects of top management team and board 
compositions on R&D investment strategy. Strategic Management Journal, 27(11),  
1081-1099. 
 
Krafft, J., & Ravix, J-L. 2005. Corporate governance and the governance of 
knowledge: rethinking the relationship in terms of corporate coherence. Economics 
of Innovation and New Technology,  14(3-4), 1-25. 
 
Kristensen, P.H. & Zeitlin, J. 2005.  Local Players in Global Games: the strategic 
constitution of a multinational corporation.  Oxford University Press. 
 
Lacetera, N. 2001. Corporate governance and the governance of innovation: the 
case of the pharmaceutical industry.  Journal of Management and Governance, 5,  
29-59. 
 
Lang, G. 2009.  Measuring the returns of R&D – an empirical study of the German 
manufacturing sector over 45 years.  Research Policy,  38(9), 1438-1455. 
 
Lazonick,  W. 2008. The quest for shareholder value: stock repurchases in the US 
economy. Recherches économiques de Louvain,  74(4),  479-540. 
 
Lazonick, W. 2010. The Chandlerian corporation and the theory of innovative 
enterprise.  Industrial and  Corporate Change,  19(2), 317-349. 
 
Lee, P.M..& O’Neill, H. M.  2003. Ownership structures and R&D investments of US 
and Japanese Firms: agency and stewardship perspectives. Academy of 
Management Journal 46(2),  212-25. 
 
Lerner, J., & Wulf, J. 2006. Innovation and Incentives: evidence from corporate R&D. 
NBER paper 11944. 
Lhuillery, S. 2011. The impact of corporate governance practices on R&D efforts: a 
look at shareholders’ rights, cross-listing and control pyramid.  Industrial and 
Corporate Change, forthcoming. . 
Love, J. H., & Roper, S. 2001. Location and network effects on innovation success: 
evidence for UK, German and Irish manufacturing plants. Research Policy, 30,  643–
661. 
 
Lundvall, B. 2002.  Innovation, Growth and Social Cohesion,: the Danish model, 




Lysandrou,  P. & Parker,  D. 2011. Commercial corporate governance ratings: an 




Malmberg, C. 2008. R&D and financial systems: The determinants of R&D 
expenditures in the Swedish pharmaceutical industry.  CIRCLE Electronic Working 
Paper Series, WP 2008/01, Lund University. 
 
Mallin,  C. 2007.  Corporate Governance, 2nd edn Oxford OUP. 
 
Mairesse, J., Hall, B. H., & Mulkay, B. 1999. Firm-level investment in France and the 
United States: An exploration of what we have learned in twenty years, Working 
Paper 7437, National Bureau of Economic Research. 
 
McDonald, R. L. 1998. Real options and rules of thumb in capital budgeting. In: 
Brennan, M.J., Trigeorgis, L. (Eds.), Innovation, Infrastructure, and Strategic 
Options. Oxford University Press, London.  
 
Moncada-Paternò-Castello, P., Ciupagea,  C., Smith,  K.  Tübke  A. & Tubbs, M.  
2010.   Does Europe perform too little corporate R&D? A comparison of EU and non-
EU corporate R&D performance.  Research Policy,  39(4), 523-536. 
Munari, F & Sobrero, M. 2003.  Corporate governance and innovation.  Chapter 1 in 
Calderini M., P. Garrone and M. Sobrero (2003) Corporate Governance and Market 
Structure and Innovation, Edward Elgar. 
 
Munari,  F.,  Oriani, R. & Sobrero, M. 2010. The effects of owner identity and 
external governance systems on R&D investments: a study of Western European 
firms.  Research Policy,  39, 1093-1104. 
 
OECD. 2004.  OECD Principles of Corporate Governance, Organisation for 
Economic Cooperation and Development, Paris. 
 
O’Mahony. M. & Vecchi, M. 2009. R&D, knowledge spillovers and company 
productivity performance.  Research Policy,  38,  35-44. 
 
O’Sullivan, M. 2005. Finance and Innovation, Chapter 9 in Fagerberg, J. , Mowery, 
D. C., &  Nelson, R. R.  (Eds.), The Oxford Handbook of Innovation, Oxford 
University Press. 
 
Palley ,T. I. 1997. Managerial turnover and the theory of short-termism. Journal of 
Economic Behavior and Organization ,32(4),  547-557. 
 
Pavitt, K. 2005. Innovation processes. In: Fagerberg, J., Mowery, D.C, & Nelson, R. 
R. (Eds.), The Oxford Handbook of Innovation; Oxford University Press. 
 
Porter, M. E. 1985. Technology and competitive advantage. Journal of Business 




Reichstein T., & Salter A. 2006. Investigating the sources of process innovation 
among UK manufacturing firms.  Industrial and Corporate Change, 15(4),  653–682. 
 
Rogers, M. 2006. R&D and productivity in the UK: Evidence from firm-level data in 
the 1990s, Economics Series Working Papers 255, University of Oxford, Department 
of Economics. 
 
Roper, S., Du, J., & Love, J. H. 2008. Modelling the innovation value chain. 
Research Policy,  37,  961–977. 
 
Saviotti, P. 1987. Research and development in the firm: Strategy and structure” in 
Coombs, R., Saviotti P., & Walsh V.  Economics and Technological Change, New 
Jersey, Rowmen and Littlefield. 
 
Smit, H., & Trigeorgis, L. 2004. Strategic Investment, Real Options and Games, 
Princeton, Princeton University Press. 
 
Smith V., Madsen, E. S., & Dilling-Hansen, M. 2001. Investment in R&D and 
corporate governance.  Quartlerly Journal of Economic Research , 263-73. 
 
Stephan, A. 2004. R&D expenditure of firms over the business cycle: Evidence for 
Germany. Study for the German Ministry of Education and Science. ZEW Mannheim, 
IFO München, DIW Berlin, Stifterverband Essen Workshop of the NIESR London. 
 
Stein, J. C. 2003. Agency, information and corporate investment, in Constantinides, 
G. M.,  Harris, M., & R. M. Stultz, R. M. (Eds.), Handbook of the Economics of 
Finance, Vol. 1A Corporate Finance, Elevier. 
 
Summers, L. 1981. Taxation and corporate investment: A Q theory approach, 
Brookings Papers on Economic Activity, 1/1981,  67-140. 
 
Taylor, M. Z. 2004. Empirical evidence against varieties of capitalism’s theory of 
technological innovation.  International Organization,   58,  601-631. 
 
Temple, P., Urga, G., & Driver, C. 2001. The influence of uncertainty on fixed 
investment in the UK: a macro or a micro phenomenon. Scottish Journal of Political 
Economy, 48(4),  361-821. 
 
Tirole,  J. 2006.  The Theory of Corporate Finance, Princeton University Press. 
 
Tylecote, A. 2007. The role of finance and corporate governance in national systems 
of innovation. Organization Studies,  28 (10),  1461-1481. 
 
Tylecote,  A. & Ramirez, P. 2006. Corporate governance: the UK compared with the 
US and “insider” economies.   Research Policy , 35(1),  160-180. 
 
Tylecote, A. & Visintin, F. 2008. Corporate Governance, Finance and the 




Ughetto,  E. 2008. Does internal finance matter for R&D: New evidence from a panel 
of Italian firms.  Cambridge Journal of Economics, 32(6),  907-25. 
 
Van Pottelsberghe, B., Honore, F. and Munari, F. 2011. Corporate governance 
practices and companies' R&D orientation: Evidence from European countries. 
Bruegel Working Paper 2011/01, 24 January 2011 
 
Vecchi, M.,  Barrel, R.,  Becker, B., Schmidt-Ehmcke, J., & Stephan, A. 2007. The 
determinants of investment in industrial research and development in the United 
Kingdom and in Germany: Final research report to the Anglo-German foundation, 
National Institute of Economic and Social Research and German Institute for 
Economic Research.  
 
Wakelin, K., 2001. Productivity Growth and R&D Expenditure in UK Manufacturing 
Firms. Research Policy, 30,  1079–1090. 
 
Windsor, D. 2009. Tightening corporate governance. Journal of International 
Management , 15,  306-316. 
 
Wu, J., & TU, R. 2007. CEO stock option pay and R&D spending: A behavioral 
agency explanation. Journal of Business Research, 60, 482-492. 
 
Yermack, D., 1996. Higher Market Valuation of Companies with a Small Board of 
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Table 1 Dependent Variable            * 





-3.4435***    
(1.0361)    
-3.9962***   
(1.0210)     
-3.8574 ***  
(0.9462)     
-4.6374***   
(0.9064)     




0.2622*   
(0.1376)      
0.1767   
(0.1538)      
0.2554*   
(0.1526)      
0.1606   
(0.1743)      




-0.7779***   
(0.1931)     
-0.9737***   
(0.1838)     
-0.7719***    
(0.1987)     
-0.9625***   
(0.1902)     




-0.0126    
(0.1052)     
0.0774    
(0.1029)      
0.0161   
(0.1022)      
0.1243   
(0.1016)      
                       -0.0378   
(0.0232)     
-0.0421*    
(0.0246)     
-0.0205   
(0.0218)     
-0.0158   
(0.0193)     
                      -0.0575*   
(0.0328)     
-0.0778**   
(0.0381)     
-0.0269   
(0.0337)     
-0.0336   
(0.0359)   
                 0.0929   
(0.0616)      
0.0215   
(0.0400)      
0.0948   
(0.0629)      
0.0249   
(0.04039)      
Time Dummies No No No No Yes Yes 
No Obs 323 237 298 216 298  
Wald  (0.0000)  (0.0000)  (0.0000) 
Sargan  (0.4738)  (0.0428)  (0.7251) 
AR(1)  (0.8932)  (0.4435)  (0.6891) 
AR(2)  (0.6207)  (0.4470)  (0.6034) 
       
* Estimation was carried out on STATA10 using the command XTREG for FE and XTABOND for 
GMM. Robust estimates are reported.  Standard errors are in parentheses. One star signifies 
significance at the 10% level; two stars at 5% and three stars at 1%. Wald is the p value for the 
overall test of significance. AR1 and AR2 are the p-values for the Arellano-Bond tests for first and 






Table 2 Dependent Variable             
 (1) FE  (2) GMM (3) GMM1 (4) FE (5) GMM (6)GMM1 
                 Constant -2.8961***    
(0.9984)     
-3.9575***   
(1.0199)    
-3.9488***   
(0.9791)    
-3.2288***   
(0.9273)    
-4.4640***   
(0.8532)     
-4.4520***   
(0.8663)     
                      0.2155*   
(0.1257)      
0.1488  
(0.1434)     
0.1485    
(0.1423)     
0.2140   
(0.1375)      
0.1395   
(0.1621)      
0.1404  
(0.1613)     
                       -0.7834***   
(0.1912)     
-0.9734***   
(0.1753)     
-0.9730***    
(0.1735)     
-0.7808***   
(0.1980)     
  -0.9681***   
(0.1827)     
-0.9705***   
(0.1804)     
                           0.0425   
(0.0867)      
0.1015   
(0.0986)      
0.1009   
(0.0976)      
0.0725    
(0.0852)     
0.1478   
(0.1016)      
(0.1449)   
(0.1033)      
                              -0.0376   
(0.0226)     
-0.0466*   
(0.0243)     
-0.0471**    
(0.0223)     
-0.0220   
(0.0216)     
-0.0233   
(0.0193)     
-0.0223   
(0.0186)     
                              -0.0489   
(0.0339)     
-0.0773**    
(0.0373)     
-0.0778**   
(0.0357)     
-0.0221   
(0.0363)     
-0.0399   
(0.0356)     
-0.0387   
(0.0355)     
                        0.0750**   
(0.0331)      
0.0700***   
(0.0241)     
0.0699***   
(0.0243)      
0.0641**    
(0.0301)     
0.0573**   
(0.0227)      
0.0571**   
(0.0225)      
            *      -0.0468**    
(0.0203)    
-0.0346**   
(0.0148)     
-0.0345**   
(0.0149)     
-0.0412**   
(0.0202)    
-0.0280**    
(0.0143)    
-0.0280**   
(0.0143)     
       Time Dummies NO NO NO YES YES YES 
                     No Obs 293 212 210 290 212 212 
                         Wald              (0.0000) (0.0000)  (0.0000) (0.0000) 
                       Sargan  (0.1148) (0.1526)  (0.7237) (0.7731) 
                        AR(1)  (0.3317) (0.3340)  (0.6029) (0.6125) 
                        AR(2)  (0.7340) (0.7331)  (0.9233) (0.9262) 
See Notes to Table 1.  GMM1 includes lagged value of the industry mean levels governance variable 




Table 3 Dependent Variable            * 
 
 (1)GMM (2)GMM (3)GMM (4)GMM (5)GMM (6)GMM 
Constant -4.1478*** 
(0.9929) 
-3.5139***   
(0.9885)     
-3.7412***   
(1.0665)    
-3.8116***   
(1.1039)     
-4.2801***    
(0.9890)     
-4.5234***   
(0.9882)     
              0.2026 
(0.1408) 
0.1924    
(0.1455)     
0.2019   
(0.1444)      
0.1884   
(0.1722)      
0.1678   
(0.1602)      
0.1839   
(0.1590)      
               -0.9699*** 
(0.1712) 
-0.9878***    
(0.1639)    
-0.9828***   
(0.1673)    
-1.0342***   
(0.1967)     
-0.9826***   
(0.1730)     
-0.9832***   
(0.1701)     
                   0.0731 
(0.1066) 
0.0066   
(0.1037)      
0.0567   
(0.1256)      
-0.0236   
(0.1264)     
0.0627   
(0.1067)      
0.0954   
(0.1078)      
                      -0.1219* 
(0.0667) 
-0.0966*   
(0.0543)     
0.0078   
(0.0302)     
-0.1749   
(0.1993)     
0.3120***   
(0.0952)     
-1.3889   
(1.4804)     
                     -0.1432* 
(0.0758) 
-0.2046**    
(0.0974)    
-0.1176**   
(0.0566)     
-0.4626*   
(0.2707)     
0.3067**   
(0.1197)      
2.8031**   
(1.4143)      
               0.0232 
(0.0392) 
0.0185   
(0.0331)      
0.0043   
(0.0334)      
0.0480   
(0.0508)      
0.0242   
(0.0366)      
0.0200   
(0.0372)      
        
No Obs 216 221 221 190 216 216 
Wald (0.0000) (0.0000) (0.0000) (0.0000) (0.0000) (0.0000) 
Sargan (0.0000) (0.0151) (0.0004) (0.0959) (0.8427) (0.6661) 
AR(1) (0.2706) (0.4821) (0.1391) (0.6086) (0.6124) (0.4890) 
AR(2) (0.7507) (0.6462) (0.4910) (0.2042) (0.5236) (0.5777) 
 
*See Notes to Tables 1.  
Each column (1) to (6) has CGX(.) defined differently where the column number is (,). 
In terms of the definitions in Section 4.2.: 
CGX1 is the sum of the Bonus and Stock & Option dummies 
CGX2 is the dummy variable Board size  
CGX3 is the sum of  Observance of Higgs and Separation of Powers dummies 
The ownership variables are as follows: 
CGX4  is defined as a dummy=1 for existence of at least one shareholder with 
ownership>5% of the total. 
CGX5 is defined as a dummy=1 for CEO share ownership  > 1% 
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